nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanechol—Borborygmi—Orlistat—type 2 diabetes mellitus	0.134	0.176	CcSEcCtD
Bethanechol—Gastrointestinal sounds abnormal—Orlistat—type 2 diabetes mellitus	0.0555	0.0732	CcSEcCtD
Bethanechol—Abdominal colic—Orlistat—type 2 diabetes mellitus	0.0473	0.0623	CcSEcCtD
Bethanechol—Sensation of warmth—Irbesartan—type 2 diabetes mellitus	0.0207	0.0272	CcSEcCtD
Bethanechol—L-Carnitine—CPT1A—type 2 diabetes mellitus	0.0197	1	CrCbGaD
Bethanechol—Abdominal cramps—Bromocriptine—type 2 diabetes mellitus	0.0127	0.0168	CcSEcCtD
Bethanechol—Sweating—Nateglinide—type 2 diabetes mellitus	0.00764	0.0101	CcSEcCtD
Bethanechol—Feeling hot—Irbesartan—type 2 diabetes mellitus	0.00709	0.00934	CcSEcCtD
Bethanechol—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.00685	0.00902	CcSEcCtD
Bethanechol—Eructation—Orlistat—type 2 diabetes mellitus	0.00629	0.00828	CcSEcCtD
Bethanechol—Ill-defined disorder—Tolazamide—type 2 diabetes mellitus	0.00624	0.00822	CcSEcCtD
Bethanechol—Malaise—Tolazamide—type 2 diabetes mellitus	0.00606	0.00799	CcSEcCtD
Bethanechol—Discomfort—Tolazamide—type 2 diabetes mellitus	0.00565	0.00745	CcSEcCtD
Bethanechol—Pollakiuria—Glimepiride—type 2 diabetes mellitus	0.00552	0.00727	CcSEcCtD
Bethanechol—Sweating—Glipizide—type 2 diabetes mellitus	0.00547	0.00721	CcSEcCtD
Bethanechol—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.0053	0.00698	CcSEcCtD
Bethanechol—Sweating—Pioglitazone—type 2 diabetes mellitus	0.00524	0.00691	CcSEcCtD
Bethanechol—Sweating—Glimepiride—type 2 diabetes mellitus	0.00511	0.00673	CcSEcCtD
Bethanechol—Pollakiuria—Bromocriptine—type 2 diabetes mellitus	0.00498	0.00656	CcSEcCtD
Bethanechol—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.00491	0.00647	CcSEcCtD
Bethanechol—Flushing—Glipizide—type 2 diabetes mellitus	0.00475	0.00626	CcSEcCtD
Bethanechol—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00459	0.00605	CcSEcCtD
Bethanechol—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.00452	0.00596	CcSEcCtD
Bethanechol—Asthma—Gliclazide—type 2 diabetes mellitus	0.00442	0.00583	CcSEcCtD
Bethanechol—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.00436	0.00575	CcSEcCtD
Bethanechol—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00417	0.00549	CcSEcCtD
Bethanechol—Ill-defined disorder—Glipizide—type 2 diabetes mellitus	0.00414	0.00545	CcSEcCtD
Bethanechol—Malaise—Glipizide—type 2 diabetes mellitus	0.00402	0.0053	CcSEcCtD
Bethanechol—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00402	0.00529	CcSEcCtD
Bethanechol—Asthma—Orlistat—type 2 diabetes mellitus	0.00402	0.00529	CcSEcCtD
Bethanechol—Nausea—Miglitol—type 2 diabetes mellitus	0.00398	0.00525	CcSEcCtD
Bethanechol—Ill-defined disorder—Pioglitazone—type 2 diabetes mellitus	0.00396	0.00522	CcSEcCtD
Bethanechol—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00395	0.0052	CcSEcCtD
Bethanechol—Malaise—Pioglitazone—type 2 diabetes mellitus	0.00385	0.00508	CcSEcCtD
Bethanechol—Ill-defined disorder—Sitagliptin—type 2 diabetes mellitus	0.00385	0.00507	CcSEcCtD
Bethanechol—Sweating—Gliclazide—type 2 diabetes mellitus	0.00378	0.00498	CcSEcCtD
Bethanechol—Headache—Tolbutamide—type 2 diabetes mellitus	0.00378	0.00498	CcSEcCtD
Bethanechol—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00375	0.00495	CcSEcCtD
Bethanechol—Discomfort—Glipizide—type 2 diabetes mellitus	0.00375	0.00494	CcSEcCtD
Bethanechol—Malaise—Sitagliptin—type 2 diabetes mellitus	0.00374	0.00493	CcSEcCtD
Bethanechol—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00371	0.00489	CcSEcCtD
Bethanechol—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00361	0.00475	CcSEcCtD
Bethanechol—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00361	0.00475	CcSEcCtD
Bethanechol—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.00359	0.00473	CcSEcCtD
Bethanechol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00358	0.00472	CcSEcCtD
Bethanechol—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.00352	0.00464	CcSEcCtD
Bethanechol—Asthma—Irbesartan—type 2 diabetes mellitus	0.00349	0.0046	CcSEcCtD
Bethanechol—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.00349	0.0046	CcSEcCtD
Bethanechol—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00348	0.00458	CcSEcCtD
Bethanechol—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00348	0.00458	CcSEcCtD
Bethanechol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00344	0.00453	CcSEcCtD
Bethanechol—Headache—Tolazamide—type 2 diabetes mellitus	0.00344	0.00453	CcSEcCtD
Bethanechol—Headache—Linagliptin—type 2 diabetes mellitus	0.0034	0.00448	CcSEcCtD
Bethanechol—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.00337	0.00444	CcSEcCtD
Bethanechol—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00331	0.00437	CcSEcCtD
Bethanechol—Flushing—Gliclazide—type 2 diabetes mellitus	0.00329	0.00433	CcSEcCtD
Bethanechol—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00328	0.00433	CcSEcCtD
Bethanechol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00326	0.00429	CcSEcCtD
Bethanechol—Nausea—Tolazamide—type 2 diabetes mellitus	0.00326	0.00429	CcSEcCtD
Bethanechol—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00325	0.00429	CcSEcCtD
Bethanechol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00317	0.00418	CcSEcCtD
Bethanechol—Nausea—Acarbose—type 2 diabetes mellitus	0.00313	0.00412	CcSEcCtD
Bethanechol—Pollakiuria—Losartan—type 2 diabetes mellitus	0.00304	0.004	CcSEcCtD
Bethanechol—Nausea—Nateglinide—type 2 diabetes mellitus	0.00302	0.00398	CcSEcCtD
Bethanechol—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00301	0.00397	CcSEcCtD
Bethanechol—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.003	0.00395	CcSEcCtD
Bethanechol—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00299	0.00394	CcSEcCtD
Bethanechol—Convulsion—Glyburide—type 2 diabetes mellitus	0.00297	0.00392	CcSEcCtD
Bethanechol—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00288	0.00379	CcSEcCtD
Bethanechol—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00287	0.00379	CcSEcCtD
Bethanechol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00286	0.00377	CcSEcCtD
Bethanechol—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00286	0.00377	CcSEcCtD
Bethanechol—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00284	0.00375	CcSEcCtD
Bethanechol—Asthma—Ramipril—type 2 diabetes mellitus	0.00282	0.00371	CcSEcCtD
Bethanechol—Sweating—Losartan—type 2 diabetes mellitus	0.00281	0.0037	CcSEcCtD
Bethanechol—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.0028	0.00369	CcSEcCtD
Bethanechol—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00279	0.00368	CcSEcCtD
Bethanechol—Malaise—Gliclazide—type 2 diabetes mellitus	0.00278	0.00366	CcSEcCtD
Bethanechol—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00277	0.00365	CcSEcCtD
Bethanechol—Headache—Repaglinide—type 2 diabetes mellitus	0.00276	0.00363	CcSEcCtD
Bethanechol—Flushing—Metformin—type 2 diabetes mellitus	0.00275	0.00362	CcSEcCtD
Bethanechol—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00271	0.00357	CcSEcCtD
Bethanechol—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00268	0.00354	CcSEcCtD
Bethanechol—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00268	0.00353	CcSEcCtD
Bethanechol—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00267	0.00352	CcSEcCtD
Bethanechol—Hypotension—Glyburide—type 2 diabetes mellitus	0.00262	0.00345	CcSEcCtD
Bethanechol—Nausea—Repaglinide—type 2 diabetes mellitus	0.00261	0.00344	CcSEcCtD
Bethanechol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.0026	0.00343	CcSEcCtD
Bethanechol—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.0026	0.00342	CcSEcCtD
Bethanechol—Flushing—Irbesartan—type 2 diabetes mellitus	0.00259	0.00342	CcSEcCtD
Bethanechol—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00259	0.00342	CcSEcCtD
Bethanechol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00252	0.00333	CcSEcCtD
Bethanechol—Malaise—Orlistat—type 2 diabetes mellitus	0.00252	0.00332	CcSEcCtD
Bethanechol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00249	0.00328	CcSEcCtD
Bethanechol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00247	0.00325	CcSEcCtD
Bethanechol—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00245	0.00323	CcSEcCtD
Bethanechol—Flushing—Losartan—type 2 diabetes mellitus	0.00244	0.00322	CcSEcCtD
Bethanechol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00243	0.0032	CcSEcCtD
Bethanechol—Convulsion—Orlistat—type 2 diabetes mellitus	0.00242	0.00319	CcSEcCtD
Bethanechol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00242	0.00319	CcSEcCtD
Bethanechol—Sweating—Ramipril—type 2 diabetes mellitus	0.00241	0.00317	CcSEcCtD
Bethanechol—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00239	0.00315	CcSEcCtD
Bethanechol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00239	0.00314	CcSEcCtD
Bethanechol—Discomfort—Orlistat—type 2 diabetes mellitus	0.00235	0.0031	CcSEcCtD
Bethanechol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00235	0.0031	CcSEcCtD
Bethanechol—Malaise—Metformin—type 2 diabetes mellitus	0.00233	0.00306	CcSEcCtD
Bethanechol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00232	0.00306	CcSEcCtD
Bethanechol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00232	0.00305	CcSEcCtD
Bethanechol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00231	0.00304	CcSEcCtD
Bethanechol—Headache—Glipizide—type 2 diabetes mellitus	0.00228	0.003	CcSEcCtD
Bethanechol—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00226	0.00297	CcSEcCtD
Bethanechol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00221	0.00292	CcSEcCtD
Bethanechol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00221	0.00291	CcSEcCtD
Bethanechol—Malaise—Irbesartan—type 2 diabetes mellitus	0.00219	0.00289	CcSEcCtD
Bethanechol—Headache—Pioglitazone—type 2 diabetes mellitus	0.00218	0.00288	CcSEcCtD
Bethanechol—Discomfort—Metformin—type 2 diabetes mellitus	0.00217	0.00286	CcSEcCtD
Bethanechol—Nausea—Glipizide—type 2 diabetes mellitus	0.00216	0.00285	CcSEcCtD
Bethanechol—Hypotension—Valsartan—type 2 diabetes mellitus	0.00216	0.00284	CcSEcCtD
Bethanechol—Headache—Glimepiride—type 2 diabetes mellitus	0.00213	0.0028	CcSEcCtD
Bethanechol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00212	0.0028	CcSEcCtD
Bethanechol—Headache—Sitagliptin—type 2 diabetes mellitus	0.00212	0.00279	CcSEcCtD
Bethanechol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.0021	0.00276	CcSEcCtD
Bethanechol—Flushing—Ramipril—type 2 diabetes mellitus	0.00209	0.00276	CcSEcCtD
Bethanechol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00207	0.00273	CcSEcCtD
Bethanechol—Malaise—Losartan—type 2 diabetes mellitus	0.00206	0.00272	CcSEcCtD
Bethanechol—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00205	0.0027	CcSEcCtD
Bethanechol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00203	0.00268	CcSEcCtD
Bethanechol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00202	0.00266	CcSEcCtD
Bethanechol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00201	0.00265	CcSEcCtD
Bethanechol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00199	0.00262	CcSEcCtD
Bethanechol—Hypotension—Metformin—type 2 diabetes mellitus	0.00197	0.00259	CcSEcCtD
Bethanechol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00194	0.00255	CcSEcCtD
Bethanechol—Discomfort—Losartan—type 2 diabetes mellitus	0.00193	0.00254	CcSEcCtD
Bethanechol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00192	0.00253	CcSEcCtD
Bethanechol—Headache—Bromocriptine—type 2 diabetes mellitus	0.00192	0.00253	CcSEcCtD
Bethanechol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00192	0.00253	CcSEcCtD
Bethanechol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00188	0.00248	CcSEcCtD
Bethanechol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00186	0.00244	CcSEcCtD
Bethanechol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00183	0.00241	CcSEcCtD
Bethanechol—Tachycardia—Losartan—type 2 diabetes mellitus	0.00182	0.0024	CcSEcCtD
Bethanechol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00182	0.0024	CcSEcCtD
Bethanechol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00182	0.0024	CcSEcCtD
Bethanechol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00181	0.00238	CcSEcCtD
Bethanechol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.0018	0.00238	CcSEcCtD
Bethanechol—Malaise—Ramipril—type 2 diabetes mellitus	0.00177	0.00233	CcSEcCtD
Bethanechol—Headache—Glyburide—type 2 diabetes mellitus	0.00175	0.00231	CcSEcCtD
Bethanechol—Hypotension—Losartan—type 2 diabetes mellitus	0.00175	0.0023	CcSEcCtD
Bethanechol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00173	0.00228	CcSEcCtD
Bethanechol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00172	0.00227	CcSEcCtD
Bethanechol—Convulsion—Ramipril—type 2 diabetes mellitus	0.0017	0.00224	CcSEcCtD
Bethanechol—Nausea—Glyburide—type 2 diabetes mellitus	0.00166	0.00219	CcSEcCtD
Bethanechol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00166	0.00219	CcSEcCtD
Bethanechol—Discomfort—Ramipril—type 2 diabetes mellitus	0.00165	0.00218	CcSEcCtD
Bethanechol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00164	0.00216	CcSEcCtD
Bethanechol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00158	0.00208	CcSEcCtD
Bethanechol—Headache—Gliclazide—type 2 diabetes mellitus	0.00158	0.00208	CcSEcCtD
Bethanechol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00157	0.00207	CcSEcCtD
Bethanechol—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00156	0.00206	CcSEcCtD
Bethanechol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00156	0.00206	CcSEcCtD
Bethanechol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00155	0.00204	CcSEcCtD
Bethanechol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00154	0.00203	CcSEcCtD
Bethanechol—Hypotension—Ramipril—type 2 diabetes mellitus	0.0015	0.00197	CcSEcCtD
Bethanechol—Nausea—Gliclazide—type 2 diabetes mellitus	0.00149	0.00197	CcSEcCtD
Bethanechol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00148	0.00195	CcSEcCtD
Bethanechol—Headache—Valsartan—type 2 diabetes mellitus	0.00145	0.00191	CcSEcCtD
Bethanechol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00144	0.0019	CcSEcCtD
Bethanechol—Headache—Orlistat—type 2 diabetes mellitus	0.00143	0.00188	CcSEcCtD
Bethanechol—Nausea—Valsartan—type 2 diabetes mellitus	0.00137	0.00181	CcSEcCtD
Bethanechol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00136	0.00179	CcSEcCtD
Bethanechol—Nausea—Orlistat—type 2 diabetes mellitus	0.00136	0.00179	CcSEcCtD
Bethanechol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00132	0.00174	CcSEcCtD
Bethanechol—Headache—Metformin—type 2 diabetes mellitus	0.00132	0.00174	CcSEcCtD
Bethanechol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00128	0.00168	CcSEcCtD
Bethanechol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00127	0.00167	CcSEcCtD
Bethanechol—Nausea—Metformin—type 2 diabetes mellitus	0.00125	0.00165	CcSEcCtD
Bethanechol—Headache—Irbesartan—type 2 diabetes mellitus	0.00124	0.00164	CcSEcCtD
Bethanechol—Nausea—Irbesartan—type 2 diabetes mellitus	0.00118	0.00155	CcSEcCtD
Bethanechol—Headache—Losartan—type 2 diabetes mellitus	0.00117	0.00154	CcSEcCtD
Bethanechol—Nausea—Losartan—type 2 diabetes mellitus	0.00111	0.00146	CcSEcCtD
Bethanechol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.0011	0.00144	CcSEcCtD
Bethanechol—Headache—Ramipril—type 2 diabetes mellitus	0.001	0.00132	CcSEcCtD
Bethanechol—Nausea—Ramipril—type 2 diabetes mellitus	0.000952	0.00125	CcSEcCtD
Bethanechol—CHRM3—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.00015	0.000678	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000149	0.000675	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000149	0.000673	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000149	0.000671	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000147	0.000665	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000146	0.000659	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000143	0.000647	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GLP1R—type 2 diabetes mellitus	0.000142	0.000641	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000142	0.000641	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000139	0.000629	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000138	0.000623	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000138	0.000623	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000137	0.000619	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000137	0.000617	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000136	0.000613	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000133	0.000602	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000133	0.000599	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000132	0.000597	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000132	0.000596	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000131	0.000591	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.00013	0.000589	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CPT1A—type 2 diabetes mellitus	0.00013	0.000587	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—MTR—type 2 diabetes mellitus	0.00013	0.000587	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000129	0.000583	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NAMPT—type 2 diabetes mellitus	0.000127	0.000575	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—HBA1—type 2 diabetes mellitus	0.000127	0.000572	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—LIPC—type 2 diabetes mellitus	0.000127	0.000572	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GCK—type 2 diabetes mellitus	0.000127	0.000572	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000126	0.000568	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000124	0.00056	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000123	0.000558	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000123	0.000555	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000123	0.000555	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CETP—type 2 diabetes mellitus	0.000122	0.000551	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000122	0.00055	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000122	0.00055	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000122	0.00055	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000121	0.000545	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000121	0.000545	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.00012	0.000542	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000119	0.000537	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000119	0.000536	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000119	0.000536	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000118	0.000535	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000118	0.000535	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000118	0.000534	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000118	0.000532	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000118	0.000531	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000118	0.000531	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000117	0.00053	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000117	0.00053	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000117	0.000528	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000117	0.000527	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000116	0.000522	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SREBF1—type 2 diabetes mellitus	0.000113	0.000513	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PSMD6—type 2 diabetes mellitus	0.000113	0.000513	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SNAP25—type 2 diabetes mellitus	0.000113	0.000513	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000113	0.000509	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000112	0.000504	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CTGF—type 2 diabetes mellitus	0.000111	0.000503	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000111	0.000501	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—HMGCR—type 2 diabetes mellitus	0.00011	0.000499	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.00011	0.000496	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000108	0.00049	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000108	0.000488	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000107	0.000485	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000107	0.000483	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000106	0.000479	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000106	0.000478	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000105	0.000475	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000105	0.000473	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000104	0.000472	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000104	0.00047	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000104	0.000469	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000103	0.000467	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000103	0.000465	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000103	0.000464	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000103	0.000464	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000103	0.000464	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000103	0.000463	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000102	0.000461	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000102	0.000461	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000102	0.000459	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000102	0.000459	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000101	0.000457	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000101	0.000455	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	0.0001	0.000452	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	9.97e-05	0.00045	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	9.84e-05	0.000445	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	9.84e-05	0.000444	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	9.84e-05	0.000444	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.77e-05	0.000442	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	9.74e-05	0.00044	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.68e-05	0.000437	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.51e-05	0.00043	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.49e-05	0.000429	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.49e-05	0.000429	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.42e-05	0.000426	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.4e-05	0.000424	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.4e-05	0.000424	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	9.35e-05	0.000422	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	9.26e-05	0.000418	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.23e-05	0.000417	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.19e-05	0.000415	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.19e-05	0.000415	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.14e-05	0.000413	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.1e-05	0.000411	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.1e-05	0.000411	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.03e-05	0.000408	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.99e-05	0.000406	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.99e-05	0.000406	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.95e-05	0.000404	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.91e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.91e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.88e-05	0.000401	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.8e-05	0.000397	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.64e-05	0.00039	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.55e-05	0.000386	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	8.48e-05	0.000383	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.48e-05	0.000383	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	8.44e-05	0.000381	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.37e-05	0.000378	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.33e-05	0.000376	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	8.33e-05	0.000376	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.29e-05	0.000374	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.25e-05	0.000373	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	8.23e-05	0.000372	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.23e-05	0.000372	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	8.15e-05	0.000368	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.15e-05	0.000368	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.09e-05	0.000366	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	8.09e-05	0.000365	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.07e-05	0.000364	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.02e-05	0.000362	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.99e-05	0.000361	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	7.87e-05	0.000355	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	7.72e-05	0.000349	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.7e-05	0.000348	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.62e-05	0.000344	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.56e-05	0.000342	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	7.56e-05	0.000341	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.56e-05	0.000341	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	7.53e-05	0.00034	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.49e-05	0.000338	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.48e-05	0.000338	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	7.34e-05	0.000331	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	7.24e-05	0.000327	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.16e-05	0.000323	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.09e-05	0.00032	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.09e-05	0.00032	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.02e-05	0.000317	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	7e-05	0.000316	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	7e-05	0.000316	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.96e-05	0.000315	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	6.95e-05	0.000314	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.93e-05	0.000313	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.93e-05	0.000313	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.93e-05	0.000313	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.9e-05	0.000312	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.87e-05	0.00031	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.86e-05	0.00031	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	6.82e-05	0.000308	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.8e-05	0.000307	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	6.76e-05	0.000305	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.73e-05	0.000304	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.7e-05	0.000302	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.67e-05	0.000301	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.65e-05	0.000301	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	6.6e-05	0.000298	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.59e-05	0.000298	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	6.49e-05	0.000293	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	6.47e-05	0.000292	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	6.46e-05	0.000292	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	6.4e-05	0.000289	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.39e-05	0.000289	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.32e-05	0.000286	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.26e-05	0.000283	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.06e-05	0.000274	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6e-05	0.000271	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.95e-05	0.000269	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.89e-05	0.000266	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	5.81e-05	0.000263	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	5.76e-05	0.00026	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	5.64e-05	0.000255	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.54e-05	0.00025	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.53e-05	0.00025	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—INS—type 2 diabetes mellitus	5.53e-05	0.00025	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	5.52e-05	0.00025	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.49e-05	0.000248	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.48e-05	0.000247	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.47e-05	0.000247	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.43e-05	0.000245	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	5.41e-05	0.000244	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	5.41e-05	0.000244	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.38e-05	0.000243	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.36e-05	0.000242	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.36e-05	0.000242	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.35e-05	0.000242	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.3e-05	0.000239	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.1e-05	0.000231	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	5.07e-05	0.000229	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.05e-05	0.000228	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.85e-05	0.000219	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	4.85e-05	0.000219	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.83e-05	0.000218	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.78e-05	0.000216	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	4.62e-05	0.000209	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	4.58e-05	0.000207	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.55e-05	0.000205	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.5e-05	0.000203	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.47e-05	0.000202	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.47e-05	0.000202	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.45e-05	0.000201	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	4.43e-05	0.0002	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.43e-05	0.0002	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.42e-05	0.0002	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.41e-05	0.000199	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.25e-05	0.000192	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.2e-05	0.00019	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.05e-05	0.000183	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.05e-05	0.000183	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.01e-05	0.000181	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.01e-05	0.000181	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.82e-05	0.000172	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.78e-05	0.000171	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.47e-05	0.000157	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.44e-05	0.000155	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.44e-05	0.000155	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.42e-05	0.000154	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.41e-05	0.000154	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.39e-05	0.000153	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.25e-05	0.000147	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.22e-05	0.000146	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.22e-05	0.000145	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.19e-05	0.000144	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.15e-05	0.000143	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.12e-05	0.000141	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	3e-05	0.000135	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.97e-05	0.000134	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.92e-05	0.000132	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.89e-05	0.000131	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.68e-05	0.000121	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.65e-05	0.00012	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.63e-05	0.000119	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.6e-05	0.000118	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	2.23e-05	0.000101	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.02e-05	9.13e-05	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2e-05	9.04e-05	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.86e-05	8.42e-05	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.85e-05	8.34e-05	CbGpPWpGaD
